NRXP
NRX Pharmaceuticals Inc
NASDAQ: NRXP · HEALTHCARE · BIOTECHNOLOGY
$2.98
+2.41% today
Updated 2026-04-30
Market cap
$100.19M
P/E ratio
—
P/S ratio
81.79x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$2 – $4
Volume
0.9M
NRX Pharmaceuticals Inc (NRXP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+49.8%
Last 4 quarters
Revenue YoY growth
+24475.0%
Most recent quarter
EPS YoY growth
+123.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+36.2%
2026-03-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-24 | $0.18 | +329.1% | $1.77 | $2.41 | +36.2% |
| 2025-11-14 | $-0.27 | +48.1% | $2.59 | $2.11 | -18.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.08 | $0.18 | +329.1% | $983000.00 | +24475.0% |
| 2025-09-30 | $-0.52 | $-0.27 | +48.1% | $242000.00 | — |
| 2025-06-30 | $-0.53 | $-0.98 | -84.9% | — | — |
| 2025-03-31 | $-0.53 | $-0.34 | +35.8% | $4000.00 | -50.0% |
| 2024-12-31 | $-0.37 | $-0.77 | -108.1% | $4000.00 | -50.0% |
| 2024-09-30 | $-0.64 | $-0.15 | +76.6% | — | — |
| 2024-06-30 | $-0.69 | $-0.67 | +2.9% | — | — |
| 2024-03-31 | $-0.55 | $-0.74 | -34.5% | $8000.00 | — |
| 2023-12-31 | $-0.70 | $-0.50 | +28.6% | $8000.00 | — |
| 2023-09-30 | $-0.11 | $-0.07 | +36.4% | — | — |
| 2023-06-30 | $-0.14 | $-0.12 | +14.3% | — | — |
| 2023-03-31 | $-0.14 | $-0.16 | -14.3% | — | — |
Frequently asked questions
Has NRX Pharmaceuticals Inc beaten earnings estimates?
NRX Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +49.8% over the last 4 quarters.
How does NRXP stock react to earnings?
NRXP stock has moved an average of +8.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is NRX Pharmaceuticals Inc's revenue growth rate?
NRX Pharmaceuticals Inc reported year-over-year revenue growth of +24475.0% in its most recent quarter, with EPS growing +123.8% year-over-year.